Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 2/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.46 |
| ▸ | OXTR | P30559 | 1/20 | 0.43 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3225799 | 1.00 | SCD (0.46) | SCDHSD11B1OXTRAOC3 | |
| SCHEMBL3225971 | 0.87 | SCD (0.49) | SCDHSD11B1OXTRAOC3 | |
| SCHEMBL3225964 | 0.87 | SCD (0.49) | SCDHSD11B1OXTRAOC3 | |
| SCHEMBL3228116 | 0.86 | NPC1L1 (0.48) | SCDHSD11B1 | |
| SCHEMBL3231690 | 0.84 | DCTPP1 (0.52) | SCD | |
| SCHEMBL3231697 | 0.84 | DCTPP1 (0.52) | SCD | |
| SCHEMBL3226802 | 0.84 | SCD (0.45) | SCDHSD11B1OXTRAOC3 | |
| SCHEMBL3220070 | 0.84 | SCD (0.51) | SCD | |
| SCHEMBL3226996 | 0.84 | AOC3 (0.44) | SCDHSD11B1OXTRAOC3 | |
| SCHEMBL3226814 | 0.84 | SCD (0.45) | SCDHSD11B1OXTRAOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8575167-B2 | Spiro compounds having stearoyl-CoA desaturase action | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-11-05 | — | — | US | disclosed |
| US-20100069351-A1 | SPIRO COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069351-A1 | SPIRO COMPOUND AND USE THEREOF | SCD, SPR, SCD5 | SCD 1/4885HSD11B1 9/4885OXTR 1108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.